CymitQuimica logo
Apoptosis

Apoptosis

Apoptosis inhibitors are compounds that prevent or delay the process of programmed cell death, known as apoptosis. These inhibitors are vital in studying cell survival mechanisms and are used to investigate diseases where apoptosis is dysregulated, such as cancer, neurodegenerative disorders, and autoimmune diseases. By modulating apoptosis, these inhibitors can help in the development of therapies aimed at controlling cell death. At CymitQuimica, we provide a comprehensive selection of high-quality apoptosis inhibitors to support your research in cell biology, oncology, and related fields.

Subcategories of "Apoptosis"

Show 6 more subcategories

Found 6043 products of "Apoptosis"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • ZSQ836

    CAS:

    ZSQ836 is a dual covalent inhibitor of CDK12/CDK13 with oral bioactivity, displaying an EC50 value of 32 nM against CDK12. This compound can induce cell apoptosis (apoptosis) and demonstrates in vivo anticancer properties. ZSQ836 is applicable for research in ovarian cancer.

    Formula:C27H28AsClN6OS2
    Color and Shape:Solid
    Molecular weight:627.05

    Ref: TM-T200333

    10mg
    Discontinued
    25mg
    Discontinued
    50mg
    Discontinued
    100mg
    Discontinued
    Discontinued product
  • DETD-35

    CAS:

    DETD-35 is a promising chemical compound in anti-melanoma therapy, functioning as an inhibitor of the MEK-ERK, Akt, and STAT3 signaling pathways. It enhances cancer cell apoptosis (Apoptosis) and diminishes resistance to Vemurafenib in cancer cells. The compound exhibits IC 50 values of 2.7, 6.0, 3.9, 3.1, and 2.5 μM against melanoma cell lines B16-F10, MeWo, SK-MEL-2, A2058c, and A375c, respectively. DETD-35 offers significant potential for advancing research in melanoma treatment strategies.

    Formula:C27H24O6
    Color and Shape:Solid
    Molecular weight:444.48

    Ref: TM-T89997

    10mg
    Discontinued
    50mg
    Discontinued
    Discontinued product
  • SMIP34

    CAS:

    SMIP34 is an inhibitor of PELP1 that demonstrates the capability to reduce cell viability and colony formation. Additionally, SMIP34 induces cell apoptosis (apoptosis) and causes cell cycle arrest in the S phase. It reduces the expression of PELP1 and exhibits anti-tumor activity. SMIP34 also has potential for research in triple-negative breast cancer (TNBC).

    Formula:C20H15ClFN5O2S
    Color and Shape:Liquid
    Molecular weight:443.88

    Ref: TM-T89834

    10mg
    Discontinued
    50mg
    Discontinued
    Discontinued product